第一单位：
Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria.
作者：
Babatunde Ayodeji,Adeagbo [1]
;
Innocent Gerald,Asiimwe [2]
;
Linda,Chaba [3]
;
Aida N,Kawuma [4]
;
Francis Williams,Ojara [5]
;
Ochuko Maureen,Orherhe [6]
;
Simon Peter,Asiimwe [7]
;
Veshni,Pillay-Fuentes Lorente [8]
;
Sharon,Sawe [9]
;
Cassius M,Phogole [8]
;
Catriona,Waitt [10]
;
Samer,Mouksassi [11]
;
Goonaseelan Colin,Pillai [12]
作者单位：
Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria.
[1]
Novartis Pharmaceuticals UK Ltd, London, UK.
[2]
Strathmore Institute of Mathematical Sciences, Strathmore University, Nairobi, Kenya.;Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, California, USA.
[3]
Infectious Diseases Institute, Makerere University, Kampala, Uganda.;Pumas-AI Inc., Dover, Delaware, USA.
[4]
Infectious Diseases Institute, Makerere University, Kampala, Uganda.;Gulu University, Gulu, Uganda.
[5]
Department of Clinical Pharmacy and Pharmacy Administration, Obafemi Awolowo University, Ile-Ife, Nigeria.
[6]
Infectious Diseases Institute, Makerere University, Kampala, Uganda.
[7]
Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
[8]
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
[9]
Infectious Diseases Institute, Makerere University, Kampala, Uganda.;Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
[10]
Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco, California, USA.
[11]
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.;CP+ Associates GmbH, Basel, Switzerland.;Pharmacometrics Africa NPC, Cape Town, South Africa.
[12]
DOI
10.1002/cpt.70249
PMID
41787065
发布时间
2026-06-12
换一批
